Business Wire

KalVista Pharmaceuticals Announces Positive Phase 1 Data for Orally Disintegrating Tablet Formulation of Sebetralstat for Use in Hereditary Angioedema

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and ...
Healio

FDA approves disintegrating Cotempla tablet for ADHD

Please provide your email address to receive an email when new articles are posted on . Neos Therapeutics Inc. recently announced the FDA approved Cotempla XR-ODT, an extended-release orally ...
Monthly Prescribing Reference

Zolmitriptan Orally Disintegrating Tabs

Zolmitriptan 2.5mg, 5mg; orange flavor; contains phenylalanine. Store Zomig Tablets and zolmitriptan orally disintegrating tablets at controlled room temperature, 20 - 25ºC (68 - 77ºF) [see USP].
조선일보

Onconic launches Ja Q Bo orally disintegrating tablet for Korean patients

Korea's 37th homegrown new drug for gastroesophageal reflux disease, Ja Q Bo (ingredient name: zaztaprozan), has been released in an orally disintegrating tablet (ODT) formulation that can be taken ...
Nasdaq

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling

MALVERN, Pa., Nov. 18, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary ...
Monthly Prescribing Reference

Long-Acting, Orally-Disintegrating Tabs Approved for ADHD

Patients using Cotempla XR-ODT showed a significant improvement in ADHD symptom control vs. placebo across the classroom day. Neos Therapeutics announced that the Food and Drug Administration (FDA) ...